N, M., S, H., HA, L., SB, H., Z, P., RJ, S., . . . HC, G. (2023). Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial. Diabetes, obesity & metabolism, 25(11), 3347. https://doi.org/10.1111/dom.15234
Chicago Style (17th ed.) CitationN, McInnes, et al. "Diabetes Remission and Relapse Following an Intensive Metabolic Intervention Combining Insulin Glargine/lixisenatide, Metformin and Lifestyle Approaches: Results of a Randomised Controlled Trial." Diabetes, Obesity & Metabolism 25, no. 11 (2023): 3347. https://doi.org/10.1111/dom.15234.
MLA (9th ed.) CitationN, McInnes, et al. "Diabetes Remission and Relapse Following an Intensive Metabolic Intervention Combining Insulin Glargine/lixisenatide, Metformin and Lifestyle Approaches: Results of a Randomised Controlled Trial." Diabetes, Obesity & Metabolism, vol. 25, no. 11, 2023, p. 3347, https://doi.org/10.1111/dom.15234.